JHS Svendgaard Laboratories Limited (JHS.BO)
INR 22.23
(0.0%)
INR 22.23
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 183.68 Million INR | -52.34% |
| 2022 | 385.41 Million INR | 52.98% |
| 2021 | 251.93 Million INR | 10.83% |
| 2020 | 227.3 Million INR | -37.11% |
| 2019 | 361.42 Million INR | 9.23% |
| 2018 | 330.88 Million INR | 0.16% |
| 2017 | 330.36 Million INR | 23.74% |
| 2016 | 266.98 Million INR | -12.4% |
| 2015 | 304.77 Million INR | 2.9% |
| 2014 | 296.17 Million INR | 3.77% |
| 2013 | 285.42 Million INR | -21.63% |
| 2012 | 364.21 Million INR | 44.79% |
| 2011 | 251.54 Million INR | 161.86% |
| 2010 | 96.06 Million INR | -39.2% |
| 2009 | 157.99 Million INR | 57.59% |
| 2008 | 100.25 Million INR | 52.35% |
| 2007 | 65.8 Million INR | 99.11% |
| 2006 | 33.05 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 56.61 Million INR | 53.36% |
| 2023 Q2 | 93.08 Million INR | -15.65% |
| 2023 Q1 | 110.35 Million INR | 122.87% |
| 2023 FY | 183.68 Million INR | -52.34% |
| 2023 Q4 | 36.91 Million INR | -12.96% |
| 2023 Q3 | 42.41 Million INR | -54.44% |
| 2022 FY | 385.41 Million INR | 52.98% |
| 2022 Q1 | 90.03 Million INR | 3941.13% |
| 2022 Q2 | 100.09 Million INR | 11.17% |
| 2022 Q3 | 117.6 Million INR | 17.5% |
| 2022 Q4 | 49.51 Million INR | -57.9% |
| 2021 Q3 | 86.44 Million INR | -2.17% |
| 2021 Q2 | 88.35 Million INR | 11.16% |
| 2021 FY | 251.93 Million INR | 10.83% |
| 2021 Q1 | 79.48 Million INR | 360.41% |
| 2021 Q4 | -2.34 Million INR | -102.71% |
| 2020 Q2 | 100.26 Million INR | 68.76% |
| 2020 Q1 | 59.41 Million INR | 155.19% |
| 2020 FY | 227.3 Million INR | -37.11% |
| 2020 Q4 | -30.52 Million INR | -131.1% |
| 2020 Q3 | 98.15 Million INR | -2.1% |
| 2019 FY | 361.42 Million INR | 9.23% |
| 2019 Q1 | 103.85 Million INR | 794.37% |
| 2019 Q2 | 119.69 Million INR | 15.25% |
| 2019 Q4 | 23.28 Million INR | -79.81% |
| 2019 Q3 | 115.31 Million INR | -3.66% |
| 2018 Q4 | 11.61 Million INR | -89.39% |
| 2018 Q1 | 97.22 Million INR | -20.23% |
| 2018 FY | 330.88 Million INR | 0.16% |
| 2018 Q3 | 109.4 Million INR | 0.18% |
| 2018 Q2 | 109.2 Million INR | 12.33% |
| 2017 Q3 | 134.42 Million INR | 51.52% |
| 2017 FY | 330.36 Million INR | 23.74% |
| 2017 Q4 | 121.87 Million INR | -9.33% |
| 2017 Q2 | 88.71 Million INR | 1.06% |
| 2017 Q1 | 87.78 Million INR | -6.28% |
| 2016 FY | 266.98 Million INR | -12.4% |
| 2016 Q4 | 93.66 Million INR | 17.05% |
| 2016 Q1 | 69.58 Million INR | -15.45% |
| 2016 Q2 | 81.28 Million INR | 16.81% |
| 2016 Q3 | 80.02 Million INR | -1.56% |
| 2015 Q1 | 66.12 Million INR | 36.26% |
| 2015 FY | 304.77 Million INR | 2.9% |
| 2015 Q4 | 82.29 Million INR | 4.25% |
| 2015 Q2 | 74.87 Million INR | 13.23% |
| 2015 Q3 | 78.94 Million INR | 5.43% |
| 2014 Q3 | 70.35 Million INR | -7.55% |
| 2014 Q1 | 77.6 Million INR | 65.95% |
| 2014 FY | 296.17 Million INR | 3.77% |
| 2014 Q4 | 48.52 Million INR | -31.02% |
| 2014 Q2 | 76.09 Million INR | -1.94% |
| 2013 Q3 | 70.71 Million INR | -21.1% |
| 2013 FY | 285.42 Million INR | -21.63% |
| 2013 Q1 | 93.81 Million INR | -46.36% |
| 2013 Q2 | 89.63 Million INR | -4.46% |
| 2013 Q4 | 46.76 Million INR | -33.87% |
| 2012 Q1 | 48.61 Million INR | 0.0% |
| 2012 Q4 | 174.89 Million INR | 128.83% |
| 2012 Q2 | 86.07 Million INR | 77.06% |
| 2012 Q3 | 76.43 Million INR | -11.2% |
| 2012 FY | 364.21 Million INR | 44.79% |
| 2011 FY | 251.54 Million INR | 161.86% |
| 2010 FY | 96.06 Million INR | -39.2% |
| 2009 FY | 157.99 Million INR | 57.59% |
| 2008 FY | 100.25 Million INR | 52.35% |
| 2007 FY | 65.8 Million INR | 99.11% |
| 2006 FY | 33.05 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ador Multiproducts Limited | -2.72 Million INR | 6846.255% |
| Ambica Agarbathies Aroma & Industries Limited | 277.34 Million INR | 33.771% |
| Bajaj Consumer Care Limited | 5.06 Billion INR | 96.374% |
| Colgate-Palmolive (India) Limited | 16.44 Billion INR | 98.883% |
| Cupid Limited | 176 Million INR | -4.366% |
| Dabur India Limited | 21.91 Billion INR | 99.162% |
| Emami Limited | 10.72 Billion INR | 98.287% |
| Gillette India Limited | 5.5 Billion INR | 96.662% |
| Godrej Consumer Products Limited | 73.4 Billion INR | 99.75% |
| Hindustan Unilever Limited | 96.12 Billion INR | 99.809% |
| Hipolin Limited | 51.32 Million INR | -257.858% |
| Honasa Consumer Limited | 8.36 Billion INR | 97.805% |
| Jyothy Labs Limited | 5.16 Billion INR | 96.446% |
| Kaya Limited | 852.48 Million INR | 78.453% |
| Marico Limited | 21.36 Billion INR | 99.14% |
| N.K Industries Limited | 201.82 Million INR | 8.99% |
| PAOS INDUSTRIES LIMITED | 513 Thousand INR | -35706.043% |
| Paramount Cosmetics (India) Limited | 35.83 Million INR | -412.543% |
| Pee Cee Cosma Sope Limited | 427.25 Million INR | 57.008% |
| Procter & Gamble Hygiene and Health Care Limited | 8.13 Billion INR | 97.742% |